131 related articles for article (PubMed ID: 36257191)
21. Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.
Ng BG; Asteggiano CG; Kircher M; Buckingham KJ; Raymond K; Nickerson DA; Shendure J; Bamshad MJ; ; Ensslen M; Freeze HH
Am J Med Genet A; 2017 Nov; 173(11):2906-2911. PubMed ID: 28856833
[TBL] [Abstract][Full Text] [Related]
22. Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport.
Deutscher SL; Nuwayhid N; Stanley P; Briles EI; Hirschberg CB
Cell; 1984 Dec; 39(2 Pt 1):295-9. PubMed ID: 6498937
[TBL] [Abstract][Full Text] [Related]
23. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes.
Son YD; Jeong YT; Park SY; Kim JH
Glycobiology; 2011 Aug; 21(8):1019-28. PubMed ID: 21436238
[TBL] [Abstract][Full Text] [Related]
24. Abnormal surface expression of sialoglycans on B lymphocyte cell lines from patients with carbohydrate deficient glycoprotein syndrome I A (CDGS I A).
Bergmann M; Gross HJ; Abdelatty F; Möller P; Jaeken J; Schwartz-Albiez R
Glycobiology; 1998 Oct; 8(10):963-72. PubMed ID: 9719677
[TBL] [Abstract][Full Text] [Related]
25. Microbial glycosyltransferases for carbohydrate synthesis: alpha-2,3-sialyltransferase from Neisseria gonorrheae.
Izumi M; Shen GJ; Wacowich-Sgarbi S; Nakatani T; Plettenburg O; Wong CH
J Am Chem Soc; 2001 Nov; 123(44):10909-18. PubMed ID: 11686694
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic study of CMP-Neu5Ac hydrolysis by α2,3-sialyltransferase from Pasteurella dagmatis.
Schmölzer K; Luley-Goedl C; Czabany T; Ribitsch D; Schwab H; Weber H; Nidetzky B
FEBS Lett; 2014 Aug; 588(17):2978-84. PubMed ID: 24945729
[TBL] [Abstract][Full Text] [Related]
28. Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly.
Ednie AR; Bennett ES
J Biol Chem; 2015 Jan; 290(5):2769-83. PubMed ID: 25525262
[TBL] [Abstract][Full Text] [Related]
29. Two N-terminally truncated variants of human β-galactoside α2,6 sialyltransferase I with distinct properties for in vitro protein glycosylation.
Luley-Goedl C; Schmoelzer K; Thomann M; Malik S; Greif M; Ribitsch D; Jung C; Sobek H; Engel A; Mueller R; Schwab H; Nidetzky B
Glycobiology; 2016 Oct; 26(10):1097-1106. PubMed ID: 27102286
[TBL] [Abstract][Full Text] [Related]
30. A polarized epithelial cell mutant deficient in translocation of UDP-galactose into the Golgi complex.
Brändli AW; Hansson GC; Rodriguez-Boulan E; Simons K
J Biol Chem; 1988 Nov; 263(31):16283-90. PubMed ID: 3141404
[TBL] [Abstract][Full Text] [Related]
31. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
32. The expression of sialyltransferases is regulated by the bioavailability and biosynthesis of sialic acids.
Bork K; Weidemann W; Berneck B; Kuchta M; Bennmann D; Thate A; Huber O; Gnanapragassam VS; Horstkorte R
Gene Expr Patterns; 2017 Jan; 23-24():52-58. PubMed ID: 28351515
[TBL] [Abstract][Full Text] [Related]
33. Physiology of sialic acid capsular polysaccharide synthesis in serogroup B Neisseria meningitidis.
Masson L; Holbein BE
J Bacteriol; 1983 May; 154(2):728-36. PubMed ID: 6302082
[TBL] [Abstract][Full Text] [Related]
34. Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese-hamster ovary cells.
Jeong YT; Choi O; Son YD; Park SY; Kim JH
Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):283-91. PubMed ID: 18590515
[TBL] [Abstract][Full Text] [Related]
35. Lectin binding assays for in-process monitoring of sialylation in protein production.
Xu W; Chen J; Yamasaki G; Murphy JE; Mei B
Mol Biotechnol; 2010 Jul; 45(3):248-56. PubMed ID: 20379804
[TBL] [Abstract][Full Text] [Related]
36. Production of cytidine 5'-monophosphate N-acetylneuraminic acid using recombinant Escherichia coli as a biocatalyst.
Lee SG; Lee JO; Yi JK; Kim BG
Biotechnol Bioeng; 2002 Dec; 80(5):516-24. PubMed ID: 12355462
[TBL] [Abstract][Full Text] [Related]
37. Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression.
Jeong YT; Choi O; Lim HR; Son YD; Kim HJ; Kim JH
J Microbiol Biotechnol; 2008 Dec; 18(12):1945-52. PubMed ID: 19131698
[TBL] [Abstract][Full Text] [Related]
38. Impact of a human CMP-sialic acid transporter on recombinant glycoprotein sialylation in glycoengineered insect cells.
Mabashi-Asazuma H; Shi X; Geisler C; Kuo CW; Khoo KH; Jarvis DL
Glycobiology; 2013 Feb; 23(2):199-210. PubMed ID: 23065352
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of lobe A and lobe B of the Conserved Oligomeric Golgi complex on the stability of {beta}1,4-galactosyltransferase 1 and {alpha}2,6-sialyltransferase 1.
Peanne R; Legrand D; Duvet S; Mir AM; Matthijs G; Rohrer J; Foulquier F
Glycobiology; 2011 Jul; 21(7):864-76. PubMed ID: 21062782
[TBL] [Abstract][Full Text] [Related]
40. Caveolin-1 knockout mice have altered serum N-glycan profile and sialyltransferase tissue expression.
Chen X; Wang L; Wu Y; Zhang H; Dong W; Yu X; Huang C; Li Y; Wang S; Zhang J
J Physiol Biochem; 2022 Feb; 78(1):73-83. PubMed ID: 34462883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
